<qa>  What is the GI disease that may significantly alter absorption of oral panobinostat7. Impairment of gastrointestinal GI function or GI disease that may significantly alter the absorption of oral panobinostat e.g., ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, obstruction, or stomach andor small bowel resection 